Development and Testing of a Patient's Decision Aid for Early Breast Cancer: a New Tool to Promote Patient's Engagement in Their Healthcare Process
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• be 18 or older;
• have received/receive diagnosis of resectable breast cancer in the early stage;
• women treated or who will undergo oncological treatment for early breast cancer;
• demonstrate the absence of psychopathological features.
• be willing and able to provide written informed consent/assent for the trial
Locations
Other Locations
Italy
European Institute of Oncology
RECRUITING
Milan
Contact Information
Primary
Gabriella Pravettoni
gabriella.pravettoni@ieo.it
0039 02 57489731
Time Frame
Start Date: 2025-01-22
Estimated Completion Date: 2027-01
Participants
Target number of participants: 180
Treatments
Stakeholders
physicians involved in the diagnosis and treatment decision for patients with early breast cancer (10 oncologists, 10 breast surgeons, and 10 breast radiologists specifically).
Patients PDA group
Participants randomized in this group will receive via mail the final version of the PDA and a Qualtrics link with a battery of questionnaires
Patients control group
Patients randomized in this group will receive only the online link with the battery of questionnaires.
Related Therapeutic Areas
Sponsors
Leads: European Institute of Oncology